Research and experimental development on natural sciences and engineering
COMET BIOTECH AS
Revenue 2025
NOK 25,000
Operating profit
NOK 2,000
Equity
NOK 168,000
Incorporated
2010
Share capital
NOK 100,000
Key figures · 2025
Current ratio
15.03
Equity ratio
93.3%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 8.2% | |
| Net margin (%%) | 8.1% | |
| Return on assets (%%) | 1.1% | |
| Likviditet | ||
| Current ratio | 15.03 | |
| Working capital | 168k | |
| Soliditet | ||
| Equity ratio (%%) | 93.3% | |
| Debt-to-equity ratio | 0.07 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.